Analyzing development of improved child-resistant medication

Attention-deficit/hyperactivity disorder (ADHD) is among the most common pediatric neurodevelopmental disorders. In 2019, nearly 10% of United States (U.S.) children had a diagnosis of ADHD. Approximately 3.3 million children, or roughly 5 out of every 100 children in the U.S., are currently prescribed medication for ADHD.

Related Keywords

United States , Ohio , America , Gary Smith , Megan Craig , Study Co , National Poison Data System , America Poison Centers , American Association Of Poison Control Centers , Injury Research , Central Ohio Poison Center , Nationwide Children , Study Co Author , Poison Centers , American Association , Poison Control Centers , Poison Help Line , Abigail Wexner Research Institute , Children , Education , Health Care , Hospital , Hyperactivity , Ediatrics , Research ,